Prevalence and typology of potential drug interactions occurring in primary care patients

European Journal of General Practice

Volumn 16, Issue 2, 2010, Pages 92-99

  Lopez Picazo, Julio J ^a,b   Ruiz, Juan C ^b   Sanchez, Jose F ^b   Ariza, Angeles ^b   Aguilera, Belen ^b   Lazaro, Dolores ^c   Sanz, Gonzalo R ^c  

^a Centro de Salud Murcia Centro España Gerencia de Atención Primaria   (Spain)

^b Murcia Health Service   (Spain)

^c Murcia Health Service   (Spain)

Author keywords

Community practice; Computer technology; Drug interactions; Drug safety

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ALLOPURINOL; ANGIOTENSIN II ANTAGONIST; BENZODIAZEPINE DERIVATIVE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM SALT; CLOPIDOGREL; DIAZEPAM; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOCORTICOID; HYDROCHLOROTHIAZIDE; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; POTASSIUM SPARING DIURETIC AGENT; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SULFONYLUREA DERIVATIVE; THIAZIDE DIURETIC AGENT;

AGE; AGED; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DRUG COMPETITION; DRUG SAFETY; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACEUTICAL CARE; POLYPHARMACY; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; SEX DIFFERENCE; SPAIN;

AGE FACTORS; AGED; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; MEDICATION ERRORS; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PHYSICIAN'S PRACTICE PATTERNS; POLYPHARMACY; PREVALENCE; PRIMARY HEALTH CARE; RISK FACTORS; SEX FACTORS; SPAIN;

EID: 77952968791     PISSN: 13814788     EISSN: None     Source Type: Journal    
DOI: 10.3109/13814788.2010.481709     Document Type: Article

References (43)

1. Sandars J, Esmail A. The frequency and nature of medical error in primary care: understanding the diversity across studies. Family Practice 2003;20:231-236
2. Jacobson L, Elwyn G, Robling M, Tudor-Jones R. Error and safety in primary care: no clear boundaries. Family Practice 2003;20:237-241
3. APEAS Study: estudio sobre la seguridad de los pacientes en Atención Primaria de Salud. Madrid: Spanish Ministry of Health and Consumer Affairs; 2008.
4. Weingart SN, Wilson RM, Gibberd RW, Harrison B. Epidemiology of medical error. Br Med J. 2000;320:774-777
5. Kohn LT, Corrigan J, Donaldson MS. Toerr is human: building a safer health system. Washington DC: National Academies Press; 2000.
6. Moskowitz EJ, Nash DB. The quality and safety of ambulatory medical care: Current and future prospects. Am J Med Qual. 2007;22:274-88..
7. Woods DM, Thomas EJ, Holl JL, Weiss KB, Brennan TA. Ambulatory care adverse events and preventable adverse events leading to a hospital admission. Qual Saf Health Care 2007;16:127-131
8. Recalde JM, Zunzunegui MV, Beland F. Interacciones entre medicamentos prescritos en la población mayor de 65 años. Aten Primaria 1998;22:434-439
9. Vladislavona S, Reyes-Morales H, Torres-Arreola L Suárez-Ortega M. Potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age in family medicine clinics in Mexico City. BMC Health Serv Res. 2007;7:147.
10. Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf. 2007;30:911-918
11. Tulner L, Frankfort S, Gijsen G, Van Campen J, Koks C, Beinjnen J. Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance. Drugs Aging 2008; 25:343-355
12. Gagne JJ, Maio V, Ravinowitz C. Prevalence and predictor of potential drug-drug interactions in regione Emilia-Romagna, Italy. J Clin Pharm Ther. 2008;33:141-151
13. Perodeau GM, Poirier S, Foisy P, Ostoj M: Potential drugs interactions among the elderly in a home care program. J Geriatr Drug Therapy 1992;6:41-60.
14. American Society of Pharmacists Quality Assurance Indicators Development Group: Preliminary report of the ASHP QA indicators development group. Am J Hosp Pharm. 1991; 48:1941-1947
15. Morales FJ, Ferrer JM, Palop V. Hipertensión arterial inducida por medicamentos. Hipertensión 1992;9:331-336
16. Weideman RA, McKinney WP, Bernstein IH. Predictors of potential drug interactions. Hosp Pharm. 1998;33: 835-840
17. Coste J, Venot A. An epidemiologic approach to drug prescribing quality assessment: a study in primary care practice in France. Med Care 1999;37:1294-1307
18. Bedell SE, Jabbour S, Goldberg R, Glaser H, Gobble S, Young-Xu Y, et al. Discrepancies in the use of medications: their extent and predictors in an outpatient patient. Arch Intern Med. 2000;160:2129-2134
19. Bjerrun L, González B, Petersen G. Risk factor for potential drug interactions in general practice. Eur J Gen Pract. 2008; 14:23-29
20. Tamblyn RM, McLeod PJ, Abrahamowicz M, Laprise R. Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations. Can Med Assoc J. 1996;154:1177-1184
21. Morera T, Gervasini G, Carrillo JA, Benitez J. Using a computerized drug prescription screening system to trace drug interactions in an outpatient setting. Ann Pharmacother. 2004;38:1301-1308
22. Chen YF, Avery AJ, Neil KE, Johnson C, Dewey ME, Stockley IH. Incidence and possible causes of prescribing potentially hazardous/contraindicated drug combinations in general practice. Drug Safety 2005;28:67-80.
23. Linnarsson R. Drug interactions in primary health care. Scand J Prim Health Care 1993;11:181-186
24. Merlo J, Liedholm H, Lindblad U, Björck-LinnéA, Fält J, Lindberg G, et al. Prescription with potential drug interactions dispensed at Swedish pharmacies in January 1999: Cross sectional study. Br Med J. 2001;323:427-428
25. Bjerrum L, Andersen M, Petersen G, Kragstrup J. Exposure to potential drug interactions in primary health care. Scan J Prim Health Care 2003;21:153-158
26. Calvet A, Díez de Ulzurrun M, Pérez MT, Esteras J. Interacciones farmacológicas en tratamientos crónicos: Medidas correctoras para su prevención en un área básica de salud rural. Aten Primaria 2001;27:33-37
27. General Council of the Spanish Official College of Pharmacists. Spanish Official College of Pharmacists medications database (BOT). Available from www.portalfarma.com/home. nsf. Accessed 8 January 2006.
28. López-Picazo JJ, Barragán A, Bravo G. Cartera de servicios de Atención Primaria 2003-2004 del Servicio Murciano de Salud. ed. Consejería de Sanidad de la Región de Murcia. Murcia, 2003.
29. Miettinen OS, Cook EF. Confounding: essence and detection. Am. J. Epidemiol. 1981;114:593-603.
30. Magro L, Conforti A, Del Zotti F, Leone R, Iorio ML, Meneghelli I, et al. Identification of severe potential drugdrug interactions using an Italian general-practitioner database. Eur J Clin Pharmacol. 2008;64:303-309
31. Borrel-Carrio F, Páez C, Suñol R, Orrego C, Gil N, MartíM. Errores clínicos y eventos adversos: Percepción de los médicos de atención primaria. Aten Primaria 2006;38:25-32.
32. Hansten PD, Horn JR. Drug interactions and updates quarterly. United States: Applied Therapeutics Inc.; 2002.
33. Caraballo MO, Rodriguez A, Palma CL, Nieto M, Desongles T, Santos B. Análisis comparativo de bases de datos de interacciones en función de indicadores de calidad estructural. Farm Aten Prim 2007;5:104.
34. Rodríguez-Terol A, Caraballo MO, Palma D. Calidad estructural de las bases de datos de interacciones. Farm Hosp. 2009;33:134-146
35. Vitry A. Comparative assessment of four drug interaction compendia. Br J Clin Pharmacol. 2006;63:709-714
36. DRUGDEX® System [Internet database]. Greenwood Village, Colo: Thomson Healthcare. Updated periodically.
37. Stockley, Ivan. Stockley's drug interactions, 7th Ed. London: Pharmaceutical Press; 2005.
38. Lexi-Comp Online, Lexi-Interact™ Online, Hudson, Ohio: Lexi-Comp, Inc.; 2007; 29 January 2007. Lexi-Comp, Inc. Available from http://www.uptodate. com/crlsql/interact/ frameset.jsp
39. Drugdigest™ Interactions [Internet database]. St Louis, MO: Express Scripts, Inc. Updated periodically. Available from http://www.drugdigest.org/ wps/portal/ddigest
40. Drug Interactions Checker™ [Internet database]. Auckland, New Zealand: Drugsite Trust. Updated periodically. Available from http://www.drugs.com/drug-interactions. html
41. Brekke M, Rognstad S, Straand J, Furu K, Gjelstad S, Bjøner T, et al. Pharmacologically inappropriate prescriptions for elderly patients in general practice: How common? Scand J Prim Health Care 2008;26:80-85
42. Becker LB, Visser LE, Gelder T, Hofman A, Stricker BH. Interactions between 1992 and 2005 in people aged 55 year. Drugs Aging 2008;25:145-152
43. Astrand E, Astrand B, Antonov K, Petersson G. Potential drug interaction during three-decade study period: a cross sectional study of a prescription register. Eur J Clin Pharmacol. 2007;63;851-859